Enliven TherapeuticsELVN
那斯達克 · USD
50.08
+0.96
(+1.95%)
收盤 06/27 03:59 (UTC+8)
06/27 03:59 (UTC+8)
Enliven TherapeuticsELVN
50.08
+0.96
(+1.95%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 27,823 | 34,285 | 25,096 | 28,584 | 31,693 | - | - | - | - | - |
研發費用 | 20,687 | 21,245 | 18,225 | 21,491 | 24,895 | 20,724 | 21,258 | 18,826 | 19,970 | 17,905 |
推銷及管理費用 | 7,136 | 13,040 | 6,871 | 7,093 | 6,798 | 6,172 | 5,810 | 5,777 | 6,017 | 4,824 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -27,823 | -34,285 | -25,096 | -28,584 | -31,693 | -26,896 | -27,068 | -24,603 | -25,987 | -22,729 |
其他收入及費用 | 4,196 | 4,618 | 4,948 | 3,249 | 3,149 | 3,716 | 3,912 | 4,885 | 3,249 | 3,359 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,627 | -29,667 | -20,148 | -25,335 | -28,544 | -23,180 | -23,156 | -19,718 | -22,738 | -19,370 |
所得稅 | - | - | - | - | - | - | - | 232 | - | - |
稅後純益 | -23,627 | -29,667 | -20,148 | -25,335 | -28,544 | -23,180 | -23,156 | -19,950 | -22,738 | -19,370 |
基本每股稅後盈餘(元) | -0.38 | -0.48 | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | - |
稀釋每股稅後盈餘(元) | -0.38 | -0.48 | -0.30 | -0.48 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | -0.46 |
基本平均股數(千股) | 62799.00 | 62213.00 | 62093.00 | 52105.00 | 50051.00 | 49858.00 | 48267.00 | 48075.00 | 42045.00 | - |
稀釋平均股數(千股) | 62799.00 | 62213.00 | 62093.00 | 52105.00 | 50051.00 | 49858.00 | 48267.00 | 48075.00 | 42045.00 | - |
還原基本每股稅後盈餘(元) | -0.38 | -0.48 | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | - |
還原稀釋每股稅後盈餘(元) | -0.38 | -0.48 | -0.30 | -0.48 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | -0.46 |
還原基本平均股數(千股) | 62,799 | 62,213 | 62,093 | 52,105 | 50,051 | 49,858 | 48,267 | 48,075 | 42,045 | - |
還原稀釋平均股數(千股) | 62,799 | 62,213 | 62,093 | 52,105 | 50,051 | 49,858 | 48,267 | 48,075 | 42,045 | - |
EBITDA(千元) | -23,347 | -29,566 | -20,396 | -25,181 | -28,515 | -22,124 | -22,364 | -20,243 | -23,320 | -21,080 |